Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxcyte (MXCT) Change in Inventory (2020 - 2025)

Maxcyte (MXCT) has disclosed Change in Inventory for 6 consecutive years, with $72000.0 as the latest value for Q4 2025.

  • Quarterly Change in Inventory rose 113.66% to $72000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$575000.0 through Dec 2025, up 57.78% year-over-year, with the annual reading at -$575000.0 for FY2025, 57.78% up from the prior year.
  • Change in Inventory for Q4 2025 was $72000.0 at Maxcyte, down from $107000.0 in the prior quarter.
  • The five-year high for Change in Inventory was $1.7 million in Q1 2023, with the low at -$664000.0 in Q2 2024.
  • Average Change in Inventory over 5 years is $374790.0, with a median of $179550.0 recorded in 2021.
  • The sharpest move saw Change in Inventory tumbled 218.16% in 2024, then skyrocketed 5450.0% in 2025.
  • Over 5 years, Change in Inventory stood at $1.1 million in 2021, then plummeted by 44.62% to $612300.0 in 2022, then decreased by 27.16% to $446000.0 in 2023, then crashed by 218.16% to -$527000.0 in 2024, then surged by 113.66% to $72000.0 in 2025.
  • According to Business Quant data, Change in Inventory over the past three periods came in at $72000.0, $107000.0, and -$223000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.